本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

12.15
-0.1450-1.18%
盤前11.92-0.2300-1.89%06:05 EDT
成交量:63.55萬
成交額:770.54萬
市值:16.18億
市盈率:-5.90
高:12.40
開:12.21
低:11.95
收:12.30
資料載入中...
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities